Quotes 5-day view End-of-day quote Shenzhen Stock Exchange
08/12/2022
08/15/2022
08/16/2022
08/17/2022
08/18/2022
Date
15
15.13
15.01
15.1
14.89
Last
3025605
3348170
3932891
4206825
4089211
Volume
-0.92%
+0.87%
-0.79%
+0.60%
-1.39%
Change
Estimated financial data (e) CNY USD
Sales 2022
6 493 M
957 M
957 M
Net income 2022
458 M
67,5 M
67,5 M
Net Debt 2022
1 684 M
248 M
248 M
P/E ratio 2022
17,3x
Yield 2022
1,13%
Sales 2023
7 464 M
1 100 M
1 100 M
Net income 2023
563 M
82,9 M
82,9 M
Net Debt 2023
1 710 M
252 M
252 M
P/E ratio 2023
14,0x
Yield 2023
1,42%
Capitalization
7 933 M
1 169 M
1 169 M
EV / Sales 2022
1,48x
EV / Sales 2023
1,29x
Nbr of Employees
1 351
Free-Float
22,5%
Chenguang Biotech Group Co., Ltd. is a China-based company principally engaged in the manufacture and sales of natural pigment extracts, natural spices extracts, essential oil extracts, natural supplement and medicine extracts, fat and protein and others. The Company’s products include pigment, spices, supplement and medicine products, cottonseed products and others. The Company distributes its products in...
Ratings of ChenGuang Biotech Group Co., Ltd.
All news about CHENGUANG BIOTECH GROUP CO., LTD.
06/02 Liu Yingshan signed Equity Transfer Agreement to acquire Xinjiang Tianjiao Hongan Agric.. CI
05/25 Chenguang Biotech Group Co., Ltd. Announces 2021 Final Cash Dividend Proposal on A Shar.. CI
04/27 UBS Adjusts ChenGuang Biotech's Price Target to 21.50 Yuan From 20.80 Yuan, Keeps at Bu.. MT
04/25 ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the First Quarter Ended .. CI
04/20 Chenguang Biotech Group Co., Ltd. Approves Cash Dividend CI
03/30 UBS Adjusts Chenguang Biotech Group's Price Target to 20.8 Yuan From 19, Keeps at Buy MT
03/29 ChenGuang Biotech Group Co., Ltd. Announces Final Dividend For the Year 2021 CI
02/28 ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the Full Year Ended Dece.. CI
2021 Chenguang Biotech Group Handan Co., Ltd. announced that it has received CNY 150 million.. CI
2021 Hebei ChenGuang Pharmaceutical Co., Ltd. announced that it has received CNY 81 million .. CI
2021 Hebei ChenGuang Pharmaceutical Co., Ltd. announced that it expects to receive CNY 81 mi.. CI
2021 Chenguang Biotech Group Handan Co., Ltd. announced that it expects to receive CNY 150 m.. CI
2021 ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the Nine Months Ended Se.. CI
2021 Chenguang Biotech Says Unit Plans Listing in China's Third Board CI
2021 CHENGUANG BIOTECH GROUP CO., LTD.(XS : 300138) added to S&P Global BMI IndexCI
News in other languages on CHENGUANG BIOTECH GROUP CO., LTD.
Analyst Recommendations on CHENGUANG BIOTECH GROUP CO., LTD.
Chart CHENGUANG BIOTECH GROUP CO., LTD.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends CHENGUANG BIOTECH GROUP CO., LTD.
Short Term Mid-Term Long Term Trends Neutral Bearish Neutral
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
3
Last Close Price
14,89 CNY
Average target price
20,83 CNY
Spread / Average Target
39,9%
Please enable JavaScript in your browser's settings to use dynamic charts.